In 2021, the income and expenditure of medical insurance fund increased by 15.55% and 14.16% respectively. In 2021, the total income of the national basic medical insurance fund (including maternity insurance) was 2.87 trillion yuan, an increase of 15.55% year-on-year, mainly due to the phased reduction of medical insurance premiums for employees in 2020 due to the covid-19 epidemic, with a low year-on-year base; The total expenditure was 2.40 trillion yuan, a year-on-year increase of 14.16%, mainly due to the recovery of medical visits after the normalization of epidemic prevention and control and the increase of covid-19 virus vaccine and vaccination expenses. The medical insurance fund had a net balance for the 11th consecutive year.
The available years of the accumulated balance of the medical insurance fund remained at the level of 1.5 years. By the end of 2021, the cumulative balance of national basic medical insurance (including maternity insurance) was RMB 3.61 trillion, with a year-on-year increase of 14.67%, which can be used nationwide for 1.5 years. The continued expansion of the balance depends on the strength of the combination of medical insurance cost control, such as volume procurement and cracking down on insurance fraud. As of the middle of December 2021, the previous national procurement with volume could save 129.3 billion yuan of medical insurance funds. In 2021, 23.418 billion yuan of medical insurance funds were recovered by cracking down on insurance fraud.
The two sessions proposed to continue to improve the capacity of medical and health services: the 2022 government work report proposed that the per capita financial subsidy standard for residents' medical insurance and basic public health services should be increased by 30 yuan and 5 yuan respectively, promote the centralized purchase of drugs and high-value medical consumables, and improve the direct settlement method for medical treatment in different provinces and places. We believe that these measures will further improve the coverage of medical insurance for residents and drugs, and benefit innovative drugs, traditional Chinese medicine and other varieties with large marginal benefits from medical insurance expansion.
